Cabozantinib Dose Skipping as an Alternative to Dose Reductions

Clinical trial NCT07077161 · RECRUITING

Trial details

NCT number: NCT07077161
Sponsor: dr. Tom van der Hulle
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma (RCC)

Start date: 2026-01-01
Primary completion: 2027-09-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.